Accelmed is an investor tracked by The Signal, based in United States.
| Date | Company | Round | Amount |
|---|---|---|---|
| 2021-05-19 | Cynerio | Series B | $30M |
| 2019-01-09 | Cynerio | Seed | $7M |
| 2018-01-01 | Cynerio | Seed | Undisclosed |
| Date | Company | Acquirer |
|---|---|---|
| 2025-07-21 | Cynerio | Axonius |
Data from The Signal by Return on Security — cybersecurity funding and investor intelligence.